Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R AntagonistFebruary 3, 2025
Dell ends hybrid work policy, becomes latest tech giant to force workers back to the office full-timeFebruary 3, 2025
GROCERY OUTLET INVESTOR NOTICE: Grocery Outlet Holding Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 3, 2025